Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

How does sharewise work?

1

Sign up for free

Get yourself a free user account

Show more
2

Look for a stock/index

Choose a specific stock or index

Show more
3

Discuss

Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard

Show more
4

Engage

Help us make sharewise better and help us in making it a success

Show more
sharewise ist auf Deutsch und Englisch verfügbar.
sharewise is available in German and English.

Top Buy/Sell (This Month)

Security Price Target price
Rheinmetall AG €1,904.0 €2,100.0
Micron Technology Inc. €296.35 €298.17
NVIDIA Corp. €159.00 €191.45
Security Price Target price
Arbor Realty Trust Inc. €6.71 €6.83
Carmax Inc. ? €69.19
Fortinet Inc. €67.77 €97.11

Many tell you which stocks to buy.

We measure how often they are right!

Portfolios of our members

1/2DerAlmanach100000
Total
€121,827
Cash
€1.15
Performance (%)
21.827%

Pros and Cons of these stocks (New Predictions)

B+S Banksysteme AG

WKN: 126215 / Name: B+S / Stock / Software & IT Services / Micro Cap /

Pros
1
Revenue growth > 30% per year expected
1
EBIT growth > 30% per year expected
1
Well known brand
Cons
BioNTech SE ADR

WKN: A2PSR2 / Name: BioNTech / Stock / Mid Cap /

Pros
1
Positive Image
8
Stable Large shareholder and/or long term investor
18
Innovative
Cons
16
Significant cyclical dependencies
14
Higher risks for its business
12
Low dividend yield expected
Try sharewise+ and get hundreds more matching stocks
Sign up for free!

Tops & Flops S&P 500

Security Price Change(%) (%)
Discovery Communications C €22.42 5.110%
Akamai Tech. €79.50 4.980%
NVR Inc. €6,350.0 4.100%
Lam Research Corp. €7,371.0 3.990%
Westrock Co €47.53 3.930%
Security Price Change(%) (%)
Synchrony Financial €68.50 -8.300%
Capital One Financial €200.00 -7.410%
Alliance Data Systems Corp. €64.50 -6.630%
Macy's Inc. €18.73 -5.910%
American Express Co. €307.55 -4.750%

Courses

Key figures for stocks: https://unsplash.com/@markusspiske?utm_source=unsplash&utm_medium=referral&utm_content=creditCopyText
Key figures for stocks
Keeping an eye on the various key figures is important. We tell you what they mean.
Get started on the stock market in these easy steps
This course is directed at beginners who want to get started on the stock market.

Things you will learn:
  •  What is a stock
  •  What is a fund
  •  What is an ETF
  •  How to open a depot
  •  How to manage a depot that will regularly beat managed funds
  •  Why you mostly need patience to succeed on the stock market

Predictions

buy
RPM International Inc.

Start price
Target price
Perf. (%)
€95.50
18:00
€108.07
12.01.27
-
09.01.26

buy
Jazz Pharmaceuticals plc

Start price
Target price
Perf. (%)
€137.50
18:00
€197.27
12.01.27
-
16:44

buy
Mid-America Apartment Communities Inc.

Start price
Target price
Perf. (%)
€115.35
17:30
€128.66
12.01.27
-
16:18

buy
First Horizon National Corp

Start price
Target price
Perf. (%)
€20.80
17:15
-
12.01.27
-
09.01.26

Top News

News

Big Week for Data: Q4 Earnings, Inflation Rate: https://staticx-tuner.zacks.com/images/articles/main/7b/2029.jpg
Big Week for Data: Q4 Earnings, Inflation Rate

Monday, January 12th, 2026You wouldn’t know it by Monday’s market activity, but Q4 earnings season begins this week. They get underway in earnest Tuesday morning, although as Zacks Director of

The Zacks Analyst Blog Highlights NVIDIA, Alphabet, Amazon.com and CBL & Associates Properties
The Zacks Analyst Blog Highlights NVIDIA, Alphabet, Amazon.com and CBL & Associates Properties

For Immediate Release

Chicago, IL – January 12, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and

Boot Barn's Q3 Results Highlight Strong Sales Leverage Across Channels
Boot Barn's Q3 Results Highlight Strong Sales Leverage Across Channels

Boot Barn Holdings, Inc. BOOT reported preliminary third-quarter fiscal 2026 results that surpassed management’s expectations despite cycling a strong prior-year period. Same-store sales remained

The Zacks Analyst Blog Highlights NVIDIA, Micron Technology, Credo Technology and Amtech Systems
The Zacks Analyst Blog Highlights NVIDIA, Micron Technology, Credo Technology and Amtech Systems

For Immediate Release

Chicago, IL – January 12, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and

Implied Volatility Surging for Ardent Health Stock Options
Implied Volatility Surging for Ardent Health Stock Options

Investors in Ardent Health, Inc. ARDT need to pay close attention to the stock based on moves in the options market lately. That is because the May 15, 2026 $12.50 Call had some of the highest

The Zacks Analyst Blog Highlights NVIDIA, Morgan Stanley and E.ON
The Zacks Analyst Blog Highlights NVIDIA, Morgan Stanley and E.ON

For Immediate Release

Chicago, IL – January 12, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and

PCRX Stock Down 10% as Preliminary Q4 Revenues Miss Estimates
PCRX Stock Down 10% as Preliminary Q4 Revenues Miss Estimates

Pacira BioSciences PCRX reported preliminary, unaudited total revenues of $196.9 million for the fourth quarter of 2025, which missed the Zacks Consensus Estimate of $199 million. The investors were

Zacks Industry Outlook Highlights Caterpillar, Terex and Astec Industries
Zacks Industry Outlook Highlights Caterpillar, Terex and Astec Industries

For Immediate Release

Chicago, IL – January 12, 2026 – Today, Zacks Equity Research discusses Caterpillar Inc. CAT, Terex Corp. TEX and Astec Industries ASTE.

Industry: Construction - Mining

TEVA Signs Deal With RPRX to Accelerate Development of Vitiligo Drug
TEVA Signs Deal With RPRX to Accelerate Development of Vitiligo Drug

Teva Pharmaceuticals TEVA announced a funding agreement with Royalty Pharma plc RPRX, under which the latter will provide up to $500 million to accelerate the development of Teva’s anti-IL-15

Contest

Compete in Catch the Monkey ...

... and win a prize!

Leeway

Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.

Kostenlos ausprobieren

Heibel Ticker

sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.

Kostenlos ausprobieren

sharewise

Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer sharewise+-Mitgliedschaft unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.

Jetzt kostenlos ausprobieren

sharewise

Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer sharewise+-Mitgliedschaft unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.

Jetzt kostenlos ausprobieren